Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,965 total articles
Marsh & McLennan (MMC) combines high-margin brokerage and consulting franchises, global scale, and exposure to secular growth areas (cyber, climate resilience, human capital) that support mid-to-long-term revenue expansion. Technicals are mixed, but valuation and a modest short-interest backdrop create an opportunity for a disciplined long trade: e…
Cooper-Standard (CPS) is a cyclical auto-parts supplier with improving cash flow and a reasonable valuation (P/E ~16, EV/EBITDA ~6.6). Recent refinancing terms are sub-optimal and increase near-term leverage risk, but the company's free cash flow generation and normalized margins support a tactical long swing. Entry $29.55, target $36.00, stop $26.…
Microsoft ($375.07) is trading well below its 52-week high after a broad tech pullback, but fundamentals and cash generation argue that Azure-led AI adoption will re-rate the stock. This trade idea lays out an actionable long: entry $375.07, stop $350.00, target $450.00 over a long-term horizon (180 trading days).
PLAY has been hammered to a single-digit handle in the past year and now trades at an enterprise value that looks inexpensive versus sales and EBITDA. That creates a tempting contrarian scenario. Still, negative free cash flow, margin pressure and high short interest argue for caution. This trade idea outlines a disciplined entry if management can …
Malibu Boats (MBUU) looks like a sensible soft buy at current levels. The recent EUR 150M (USD $175M) acquisition of fast‑growing Saxdor Yachts, consistent product accolades, and a healthy free cash flow profile support upside. Valuation metrics (EV/Sales ~0.59, P/S ~0.6, FCF yield ~6.7%) leave room for a mid‑term rebound into $32, while near‑term …
OPAL Fuels is a capital-intensive RNG operator that recently reported growing revenue but shrinking margins and negative free cash flow. At a market cap of $366.7M and enterprise value near $388M, the stock's fundamentals and technicals favor a tactical short or neutral stance for traders who want defined risk. Entry $2.10, target $1.40, stop $2.50…
Caledonia Mining (CMCL) is a contrarian long with a clear valuation cushion: steady cash generation from the Blanket Mine, a robust Bilboes feasibility study that points to material production growth, a 2.5% dividend, and a sub-$500M market cap. Political and regulatory headlines have compressed the multiple, creating a buying opportunity for patie…
Johnson & Johnson and Protagonist's oral IL-23 receptor antagonist Icotyde won FDA approval on 03/19/2026. The pill creates a realistic shot at taking share from AbbVie's injectable Skyrizi and expands J&J's immunology toolbox. JNJ's fundamentals (market cap $567B, EPS $11.13, FCF $19.3B) and 2.2% dividend make a measured long worthwhile into early…
General Mills (GIS) faces legitimate structural pressure from GLP-1-driven shifts in eating habits and an expanding private-label aisle, which helps explain why the stock trades near 52-week lows and sports an elevated dividend yield. Still, the company is cheap on multiple metrics (P/E ~9, EV/EBITDA ~10), generates meaningful free cash flow, and i…
NextDecade (NEXT) has been re-priced by the market after a supply shock to global LNG and a string of project wins. The company remains pre-revenue but its Rio Grande LNG progress, a strong strategic investor base and a stretched short interest profile create a technical and fundamental setup for a mid-term swing. This is a tactical, higher-risk lo…
We upgrade AMD to a tactical long. The company combines improving AI GPU and datacenter CPU momentum, clean balance sheet and solid free cash flow that make a measured buy here attractive. Technicals and macro sentiment favor a recovery toward prior highs; we lay out entry at $205.00, stop at $185.00 and target at $260.00 for a mid-term swing (45 t…
Exxon Mobil (XOM) is the largest integrated oil company with low leverage, strong free cash flow and advantaged production in the Permian and Guyana. The recent Iran conflict has pushed global crude above $100/bbl, creating a clear upside to Exxon’s near-term earnings and cash generation. We lay out a tactical mid-term long with entry, stop and tar…
ArriVent BioPharma (AVBP) is a clinical-stage oncology name trading at roughly $22.34 with a market cap near $981M. Recent company activity - including AACR preclinical posters and a pivot into a global Phase 3 for firmonertinib - has created a binary investment case. If a short scheduling delay is used to refine endpoints, broaden inclusion criter…
Planet Labs (PL) has gone from a beaten-down name to one of 2025-26's high flyers. With Q4 revenue surprise, bullish guidance and AI/defense catalysts, the stock looks bid — but valuation and momentum leave little margin for error. This note lays out a concrete trade: harvest partial profits now, protect a core position with a trailing stop, and a …
H World Group delivered a solid Q4 revenue beat and is rolling out Hanting Inn, a low-capex economy brand that could accelerate unit growth and margins. Against a $15.8B market cap, a modest P/E of 22.5 and a 3.5% dividend yield, the risk/reward favors a long trade toward $58 if management can sustain revenue/margin improvement into 2026. Entry $49…
Huntington (HBAN) trades near $15.45, a valuation that looks inexpensive relative to growth and free cash flow, while near-term catalysts (merger synergies, sector momentum, and dividend yield) could re-rate the stock. The trade below is a mid-term swing (45 trading days) long with a clear stop and target. This is not a blind buy — credit trends an…
10x Genomics (TXG) is an actionable long: the stock trades at a $2.45B market cap, is generating meaningful free cash flow ($130.1M trailing), and is moving toward a higher-margin, consumables-led revenue mix that should compress multiples and re-rate the shares. Technicals are neutral and short interest remains material, so use a defined entry and…
Alpha Tau Medical (DRTS) is a clinical-stage oncology company focused on Alpha DaRT diffusing alpha-emitter radiation therapy. The stock is trading near $7.20 with a market cap of about $634M. 2026 carries multiple catalysts and an expanding radiopharmaceutical market backdrop. This trade idea lays out an actionable long position with precise entry…
Preformed Line Products (PLPC) is a high-quality, niche infrastructure supplier benefiting from secular grid and broadband upgrades. Strong recent revenue growth, clean balance sheet, and improving margins justify a long-biased trade. Entry $275.00, target $330.00, stop $245.00 for a long-term (180 trading days) hold.
Astronics (ATRO) is trading at $66.03 after a pullback from its 52-week high. The company benefits from accelerating aircraft lighting demand, a strategic acquisition that should add ~$22M in run-rate revenue, and improving free cash flow. Valuation is rich on a P/E basis but reasonable on an EV/sales lens given aerospace peers and growth expectati…
MDA Space ($32.56) trades like a high-growth story but now carries stretched multiples (P/E 50.2, P/B 4.0) and declining technicals. With price well below short-term moving averages, heavy short interest on recent volume spikes, and upcoming execution-dependent milestones across Robotics and Satellite Systems, the easy upside is largely priced in. …
Greg Abel's early actions as CEO - a personal $15M buy and the restart of repurchases - create an actionable long trade on Berkshire Hathaway. Valuation looks reasonable (P/E ~15, P/B ~1.44) while FCF and a $1.04T market cap anchor upside. This trade targets a rebound toward the upper half of the 52-week range over a 180-trading-day horizon, with a…
Micron is trading well below its recent highs after a market pullback, but underlying fundamentals - low leverage, double-digit free cash flow, and sold-out HBM capacity - look very similar to the early stages of Nvidia's profit re-rating. This is a tradeable long: enter at $405.00, stop at $360.00, target $550.00 over a long-term, 180 trading day …
Trinity Capital (TRIN) offers a compelling income entry today: a monthly $0.17 dividend (14%+ yield) backed by a growing investment book, modest valuation (P/B ~1.07, P/E ~7.3) and a market cap around $1.2B. The trade targets mean reversion toward recent highs while collecting outsized cash distribution; downside is controlled with a sub-$13 stop i…
Apogee Therapeutics (APGE) is a clinical-stage biotech that just put itself squarely in the market's spotlight: compelling 16-week Phase 2 data, a long half-life TSLP program enabling infrequent dosing, and a 52-week APEX readout on 03/23/2026. This trade idea lays out a defined long with entry, stop and target for a long-term swing (180 trading da…
